A Large-scale Digital Survey of Patients with Localized and Advanced Prostate Cancer in Germany, the UK, and the USA
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This prostate cancer (PC) survey reveals country-specific patient journeys but consistent health-related quality of life (HRQoL). Advanced disease and comorbidities significantly impact HRQoL, suggesting a need for standardized PC care approaches.
Area Of Science
- Oncology
- Public Health
- Health Services Research
Background
- Prostate cancer (PC) patient experiences, expectations, and treatment attitudes vary globally.
- Understanding these differences is crucial for improving patient care and outcomes.
Purpose Of The Study
- To conduct a large-scale digital survey of prostate cancer patients in Germany, the UK, and the USA.
- To gain insights into the patient journey, treatment perceptions, and health-related quality of life (HRQoL).
Main Methods
- A digital survey administered to 15,824 patients with localized or advanced PC across three countries.
- Data collected on demographics, diagnosis, treatment history, therapy perception, and HRQoL.
- Descriptive statistics and regression analyses were employed to examine factors influencing HRQoL.
Main Results
- Significant variations observed in PC diagnosis methods and treatment patterns (e.g., prostatectomy vs. radiotherapy) across Germany, the UK, and the USA.
- Hormone therapy was the predominant treatment for advanced PC.
- While overall treatment satisfaction was high initially, it declined over time. Advanced disease and comorbidities were key predictors of reduced HRQoL.
Conclusions
- The PC patient journey differs significantly between Germany, the UK, and the USA.
- HRQoL is not country-dependent but is negatively impacted by advanced disease and comorbidities.
- Harmonizing PC diagnosis, treatment practices, and guidelines could enhance patient outcomes.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.